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Abstract
Background: Peak levels of troponin T (TnT) reliably predict morbidity and mortality after cardiac surgery. However,
the therapeutic window to manage CABG-related in-hospital complications may close before the peak is reached. We
investigated whether early TnT levels correlate as well with complications after coronary artery bypass grafting
(CABG) surgery.
Methods: A 12 month consecutive series of patients undergoing elective isolated CABG procedures (mini-extra-
corporeal circuit, Cardioplegic arrest) was analyzed. Logistic regression modeling was used to investigate whether
TnT levels 6 to 8 hours after surgery were independently associated with in-hospital complications (either post-
operative myocardial infarction, stroke, new-onset renal insufficiency, intensive care unit (ICU) readmission,
prolonged ICU stay (>48 hours), prolonged need for vasopressors (>24 hours), resuscitation or death).
Results: A total of 290 patients, including 36 patients with complications, was analyzed. Early TnT levels (odds ratio
(OR): 6.8, 95% confidence interval (CI): 2.2-21.4, P=.001), logistic EuroSCORE (OR: 1.2, 95%CI: 1.0-1.3, P=.007)
and the need for vasopressors during the first 6 postoperative hours (OR: 2.7, 95%CI: 1.0-7.1, P=.05) were
independently associated with the risk of complications. With consideration of vasopressor use during the first 6
postoperative hours, the sum of specificity (0.958) and sensitivity (0.417) of TnT for subsequent complications was
highest at a TnT cut-off value of 0.8 ng/mL.
Conclusion: Early TnT levels may be useful to guide ICU management of CABG patients. They predict clinically
relevant complications within a potential therapeutic window, particularly in patients requiring vasopressors during the
first postoperative hours, although with only moderate sensitivity.
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Introduction
Modern immunoassays are able to detect myocardial
troponin T (TnT) in peripheral blood serum with such a high
sensitivity that acute coronary syndromes can be diagnosed
early enough to improve the patients’ prognosis drastically
[1,2]. For the assessment of cardiac perfusion after cardiac
surgery, however, such assay sensitivity does not represent an
advantage because troponins, as well as other cardiac
ischemia markers, are almost always elevated after
interventions on the heart [3]. The direct surgical injury, the
damage associated with an insufficient cardioplegic protection
or following blood reperfusion, and the lesions due to electrical
defibrillation are all mechanisms that may affect the myocardial
integrity [4]. Therefore, immediate post-operative TnT may be
seen as a surrogate parameter globally reflecting how the heart
tolerated the intervention. However, post-operative elevation of
TnT does not necessarily imply ongoing myocardial infarction
(MI). Indeed, the definition of a precise TnT cut-off value to
characterize a postoperative myocardial infarction has been
difficult to determine, but would be clinically important [5–8].
Postoperative levels of TnT are known to correlate with early
or mid-term morbidity and mortality [6,9], possibly even with
long-term survival [10–12], and it seems that TnT levels at 48
hours post-surgery have the highest prognostic power [6,10].
Although useful as an epidemiological predictor of
postoperative complications [5,13,14], late assessment of TnT
values is of limited individual screening interest because the
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therapeutic window for perioperative acute coronary syndrome
closes just a few hours after myocardial reperfusion.
The present study aimed to explore whether early TnT
values after coronary artery bypass grafting (CABG) predicted
clinically relevant in-hospital complications. If so, this marker
might be useful to guide intensive care unit (ICU) management
toward improved hospital outcome.
Materials and Methods
The study investigated a consecutive series of patients
undergoing isolated CABG procedures at a single tertiary
referral cardiac surgery unit in Switzerland between January 1st
and December 31st 2008. Patients were identified from a
prospectively maintained institutional registry (Intellect 1.6.5,
Dendrite Clinical Systems, Henley-on-Thames, UK). Since
isolated CABG procedures were performed almost exclusively
under mini ECC (MECC), those using a regular ECC as well as
beating heart procedures were excluded to warrant a
homogenous study population. Patients with a recent
myocardial infarction (occurring less than 7 days before CABG)
were excluded as well, to avoid elevated TnT levels before
surgery. However, preoperative TnT levels were not routinely
measured in this patient population. All patients provided
informed written consent for subsequent anonymized
observational analyses of their data at the time of surgery, and
the institutional review board of the University Hospital of Berne
approved the observational design of the present investigation
as part of our regular institutional quality audit.
Study design and outcome measures
Analytic strategy was agreed before data were inspected.
The main analysis focused on independent correlations
between early postoperative TnT levels after CABG and the
occurrence of a composite of clinically relevant in-hospital
complications which included MI, stroke, new-onset renal
insufficiency, ICU stay of more than 48 hours or readmission to
the ICU, need for inotropes or vasopressors for more than 24
hours, resuscitation and death. Indication of inotropes and
vasopressors were signs of insufficient tissue perfusion despite
fluid resuscitation and presumed sufficient (norepinephrine) or
insufficient cardiac output (epinephrine, dobutamine).
Secondary analyses aimed at defining a TnT threshold level
with optimized predictive value and explored whether early TnT
levels were independently associated with long-term prognosis.
Surgery and Anesthesia
All procedures were performed via full sternotomy and under
moderate systemic hypothermia (32°C) using a MECC system
[15] (Jostra Hirlingen, Germany) and a single shot mini-
cardioplegia (100 ml CardioplexolTM, Laboratorium Dr G.
Bichsel AG, Unterseen, Switzerland). CardioplexolTM is a
crystalloid solution, which is injected directly into the aortic root.
Cardiac arrest characteristically occurs within 5-8 seconds
allowing the surgeon to proceed without any delay to the
procedure. Typically, the LIMA, the left radialis artery and/or a
segment of the great saphenous vein were used as bypass
conduits. Anesthetic protocol was standardized for all patients
and included the use of fentanyl, midazolam and isoflurane.
Predictor variables and potential confounding factors
The main predictor variable was the early postoperative TnT
level. TnT, creation kinase (CK) and CK-MB levels were all
assessed at least twice after CABG during postoperative
routine blood sampling which was scheduled at around 8 and
16 hours postop, respectively. TnT levels were measured using
a 4th generation electrochemoluminescent enzyme
immunoassay on an Elecsys 2010 platform (Roche
Diagnostics, Mannheim, Germany). The lower detection limit of
this assay is 0.01ng/L. CK levels were measured using a UV-
test on a Roche Modular P800 (Roche Diagnostics), and CK-
MB levels were measured using an electrochemoluminescent
immunoassay (ECLIA) on a Roche Modular E170 platform
(Roche Diagnostics).
Perioperative characteristics that were collected are listed in
Tables 1 and 2. Suspicion of confounding was based on
established associations with both main predictor and outcome
measure, biological plausibility or inhomogeneous distributions
at P-values < 0.1.
Data source, definitions and management of missing
values
All variables were available from the prospective electronic
registry, which includes follow-up data obtained systematically
one year after surgery, then on a regular basis. Before
analysis, data was scrutinized for completeness, plausibility
and outliers by two data managers, who were independent of
the current study. In case of missing or obviously incorrect
values, alternative data sources such as hospital records were
used for data replication.
Diagnosis of a perioperative MI was based on the recently
published Third Universal Definition of Myocardial Infarction
[16], and on the criteria used in the SYNTAX trial [17]. In brief,
an MI was assumed if 2 or more out of a set of predefined
criteria were met within the first 7 days after CABG (Table 3).
Electrocardiograms (ECG) were all evaluated independently by
a senior physician and a cardiologist, both of whom were
blinded. Postoperative echocardiography was performed by a
physician independent of the current study and only if clinically
indicated.
Postoperative new-onset renal insufficiency was defined by a
new need for dialysis or, in patients with preoperative creatinin
levels below 2mg/dl (172 µmol/L), if the postoperative creatinin
level raised above 2mg/dl and reached at least double the
preoperative value during hospitalization.
Statistical analysis
Statistical analysis was performed by a biostatistician (BG)
using SPSS for Windows (version 17.0; SPSS Inc, Chicago, IL,
USA). Continuous variables are summarized as mean ± SD or,
when skewed, as median and interquartile ranges. Non-
parametric tests (Mann-Whitney) were used for statistical
comparisons except for paired analyses comparing early and
late TnT or CK-MB levels. Dichotomous variables are
expressed in absolute numbers and percentages, and
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comparisons were made using a Chi square test. Multiple
logistic regression modeling was used to assess independent
associations between predictor and in-hospital complications.
The TnT threshold value with the best predictive value was
evaluated using ROC curve analysis. All tests were 2-sided
and P values < 0.05 were assumed to indicate statistically
significant differences.
Results
Out of 1068 consecutive patients who underwent cardiac
surgery during the study period, 290 were included in the
present investigation (Figure 1). Baseline characteristics of the
study population are summarized in Table 1, and perioperative
information is given in Table 2. Some 36 patients (12%)
suffered a complication during hospitalization (Table 4): 6 had
an MI, 4 a stroke, 8 an acute renal failure, 12 needed ICU
support for longer than 48h, 4 were secondarily readmitted to
Table 1. Characteristics of 290 patients undergoing CABG.
 without complication with complication p-Value
 (n=254) (n=36)  
Female (%) 43 (16.9%) 9 (25.0%) .248
Age (years) 65.7 ± 9.7 66.5 ± 11.1 .400
Size (cm) 170.6 ± 9.4 170.2 ± 9.5 .603
Weight (kg) 81.5 ± 14.7 78.5 ± 17.7 .275
BSA (m2) 1.9 ± 0.1 1.8 ± 0.2 .390
BMI (kg/m2) 28 ± 4.7 26.9 ± 5 .188
Diabetes (%) 69 (27.2%) 11 (30.6%) .692
Dyslipidemia (%) 207 (82.8%) 30 (83.3%) 1.000
Hypertension (%) 194 (76.4%) 31 (86.1%) .284
Smoking (%) 150 (59.3%) 23 (65.7%) .581
CV hereditary (%) 87 (37.2%) 12 (37.5%) 1.000
Serum creatinin (umol/L) 83.2 ± 23.5 107.6 ± 50.8 .006
Renal insufficiency (%) 6 (2.4%) 8 (22.2%) <0.001
COPD (%)  25 (10.0%) 8 (23.5%) .039
CCS class (%) 0 50 (19.7%) 4 (11.1%)  
 1 13 (5.1%) 1 (2.8%)  
 2 109 (42.9%) 15 (41.7%) .362
 3 57 (22.4%) 9 (25.0%)  
 4 25 (9.8%) 7 (19.4%)  
NYHA class (%) 1 106 (41.7%) 9 (25.0%) <0.001
 2 105 (41.3%) 12 (33.3%)  
 3 41 (16.1%) 12 (33.3%)  
 4 2 (.8%) 3 (8.3%)  
EuroSCORE additive 3.1 ± 2.3 5.2 ± 3 <0.001
EuroSCORE logistic 3 ± 2.6 6.7 ± 10.2 0.000
LVEF (%) 57.4 ± 12.2 50.1 ± 14.9 0.006
Urgency / Emergency (%) 42 (16.6%) 11 (30.6%) 0.063
Previous stroke (%) 10 (4.0%) 3 (8.6%) 0.205
Previous PCI (%) 0 202 (81.8%) 24 (68.6%) 0.155
 1 44 (17.8%) 11 (31.4%)  
 2 1 (.4%) 0 (.0%)  
Redo (%) 2 (.8%) 2 (5.6%) 0.770
PAOD (%) 10 (3.9%) 0 (.0%) 0.479
Carotid stenosis / previous carotid surgery (%) 22 (10.4%) 4 (12.9%) 0.754
CABG, coronary artery bypass grafting; BSA, body surface area, BMI, body mass index; COPD, chronic obstructive pulmonary disease; CCS, Canadian Cardiovascular
Society; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PAOD, peripheral arterial obstructive disease
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the ICU for various reasons, 1 patient was resuscitated and 17
required vasopressors for more than 24 hours after surgery.
One patient died on the 2nd postoperative day and the autopsy
confirmed an acute MI although all bypass grafts were open.
Patients with or without complication differed regarding
preoperative EuroSCORE, left ventricular ejection fraction
(LVEF), and serum creatinin level (p<0.001 for all 3
parameters, Table 1). In contrast, cardiovascular risk factor
profiles and severity of coronary artery disease (CAD) were
similar between the groups, as were the proportion of left main
CAD, the number of bypasses performed and the Canadian
Cardiovascular Society (CCS) class. The duration of surgery as
well as X-clamp and ECC times were also similar in both
groups (Table 2).
As expected, peak TnT (1.1±1.4 ng/ml) as well as TnT
values measured at 16 to 20 hours after surgery (1.0±1.4
ng/ml) were markedly increased in patients who suffered
postoperative complications as compared to those who did not
(0.31±0.28 ng/ml and 0.37±0.28 ng/ml, respectively, p<0.005).
Although not as marked, differences were already significant at
6 to 8 hours after surgery (0.7±0.8 ng/ml versus 0.3±0.2 ng/ml,
p = 0005; Table 5). A similar constellation was observed for
CK-MB values (Table 5). Only 12% of the patients (n=36)
required vasopressors during the first 6 postoperative hours;
Table 2. Coronary artery disease and procedure related
factors in 290 patients undergoing CABG.
 without complication with complication p-Value
 (n=254) (n=36)  
Left main (%) 33 (13.0%) 7 (19.4%) 0.303
IMA (%) 236 (92.9%) 35 (97.2%) 0.485
Operation duration (min) 199 ± 46.3 198.5 ± 55.2 0.769
Perfusion time (min) 73.2 ± 26 75.6 ± 30.5 0.935
X-clamp time (min) 47.5 ± 18.8 45.3 ± 14.6 0.643
CAD (number of vessels) 2.7 ± 0.4 2.8 ± 0.3 0.706
Distal anastomosis (n) 3.1 ± 0.8 3.2 ± 0.8 0.662
Defibrillation (%) 33 (13.0%) 7 (19.4%) 0.303
IMA, internal mammarian artery; CAD, coronary artery disease
however, this was much more likely in patients who eventually
developed a complication (33% versus 9%, p<0.001, Table 3).
Multivariate analyses adjusted for two suspected
confounding factors: the need for vasopressors during the first
6 postoperative hours and the logistic EuroSCORE which, in
turn, is representative of a number of patient-related
differences including NYHA class, pre-existing renal
insufficiency, chronic lung disease, LVEF and urgency of the
procedure. Both covariates correlated independently with the
risk of developing a clinically relevant complication. Odds ratios
(95% confidence intervals) for developing a complication were
6.82 (2.17, 21.40; P=0.001) for early TnT, 2.66 (1.00, 7.08;
P=0.05) if vasopressors were needed during the first 6
postoperative hours, and 1.17 (1.05, 1.31; P=0.007) for logistic
EuroSCORE, respectively. The overall R2 for this model was
0.359, the −2 log likelihood was 78.44 and the constant −4.68.
ROC curve analysis was used to determine an early TnT
threshold with optimized sensitivity and specificity to predict
postoperative complications (Figure 2 and Table 6). As
expected, the area under the curve (AUC) was lower for TnT
levels at 6 to 8 hours than for those at 20 hours (Figure 2A).
However, in stratified analysis considering EuroSCORE and
need for vasopressors, AUC increased considerably (Figure
2B). For instance, at a threshold level of 0.8 ng/ml, sensitivity
increased from 0.28 to 0.44 if the early need for vasopressors
was considered (Table 6).
Finally, early postoperative TnT levels were independently
associated with long-term survival, which was assessed over a
mean of 4 years (OR 4.0; CI: 2.09-7.72, p<0.001).
Discussion
Over the last decade, elective CABG has progressed to a
very standardized and safe surgical procedure with low
mortality and low rates of myocardial, neurologic, renal and
other adverse events. Although influenced by the preoperative
risk profile, the immediate postoperative course of these
patients will depend on the surgical performance and
perioperative factors. Thus, the present study focused on a
potential indicator for risk stratification of intra- and
postoperative course, and its findings suggest that early TnT
levels, when elevated, independently predict the later
Table 3. Diagnosis of perioperative myocardial infarction (MI).
Universal definition of MI (Type 5 MI)16 Definition of MI SYNTAX study 17 Definition of MI used in present study
Increase of biomarkers greater than
5x99th percentile upper reference limit
during first 72 h following CABG;
Pathological Q-waves or new left
bundle-branch block, or
angiographically documented new graft
or native coronary artery occlusion, or
imaging evidence of new loss of viable
myocardium
Within the first 7 days post intervention (PCI or CABG): Either new,
abnormal Q waves and 1 ratio of peak creatine kinase–MB (CK-MB)/
peak total CK >10% or new, abnormal Q-waves and 1 plasma level of
CK-MB 5× upper limit for normal; 7 days after any intervention
procedure (PCI or CABG): either new, abnormal Q waves or enzyme
changes defined as more than 10% of the ratio of peak CK-MB/peak
total CK on one or more than one sample (if no ratio is available—one or
more than 1 plasma level of CK-MB 5× upper limit for normal)
2 or more of the 3 following criteria within the first 7
days following CABG:1. new Q-wave or new left
bundle-branch block compared to the preoperative
echocardiography (ECG); 2. creatine kinase-MB (CK-
MB) >60 mg/l; 3. postoperative severe wall motion
abnormalities in ECG corresponding with ischemic
ECG changes or angiographically documented new
graft or native coronary artery occlusion or myocardial
necrosis diagnosed by autopsy
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting
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occurrence of clinically relevant in-hospital complications after
elective CABG procedures. The marker seemed particularly
useful in high-risk patient subsets such as those with a high
preoperative EuroSCORE or those requiring vasopressors
Figure 1.  Selection process.  
doi: 10.1371/journal.pone.0074241.g001
during the initial postoperative period. Thus, the results of the
current study, although based on the analysis of a restricted
number of selected patients, suggest that early TnT elevations
might be helpful to increase alertness for on-going, not yet
detectable, myocardial complications and to guide early and
intensified ICU management of CABG patients, with the further
aim to reduce in-hospital complications and, more generally, to
improve outcomes of CABG procedures.
Established cardiac risk scores such as the EuroSCORE are
widely accepted predictors of postoperative complications and
are useful to standardize comparisons. However, they do not
account for the surgical intervention itself, although surgical
difficulties, the duration of cross-clamping as well as the
adequacy of myocardial protection will have an obvious
influence on treatment success. Thus, complementary
appraisal of procedural markers should facilitate a more
precise risk stratification of patients admitted to the ICU after
cardiac surgery. Early TnT levels represent a biologically
Table 4. Postoperative course and distribution of
complications in 290 patients undergoing CABG.
 
without
complication with complication p-Value
 (n=254) (n=36)  
Reoperation 7 (2.8%) 3 (8.6%) .108
ICU stay (days) 0.9 ± 0.2 2 ± 1.9 <0.001
ICU >2 days (%) 0 12 (33.3%) <0.001
ICU readmission (%) 0 4 (11.1%) <0.001
ICU stay total (days) 0.9 ± 0.2 2.8 ± 4.3 <0.001
Intubation time (days) 0.5 ± 0.1 1.1 ± 0.9 <0.001
Hosp duration (days) 7.1 ± 3.2 12.1 ± 9.1 <0.001
Mortality (%) 0 1 (2.8%) .124
Stroke (%) 0 4 (11.1%) <0.001
Post-operative creatinin
(umol/L) 95.9 ± 39.9 177.4 ± 121.8 <0.001
New renal insufficiency (%) 0 8 (22.9%) <0.001
New Dialysis (%) 0 1 (2.9%) .121
Post-operative MI (%) 0 6 (16.7%) <0.001
Resuscitation (%) 0 1 (2.8%) .124
Atrial fibrillation (%) 44 (17.4%) 2 (6.3%) .129
Need for blood products (%) 119 (47.6%) 20 (64.5%) .088
Need for vasopressors at 6h
(%) 24 (9.4%) 12 (33.3%) <0.001
Need for vasopressors at 24h
(%) 0 17 (47.2%) <0.001
Adrenaline_6h (µg) 440 ± 211 630 ± 832 0.522
Dobutrex_6h (µg) 31.5 ± 22.1 50.1 ± 11.3 .061
Noradrenaline_6h (µg) 459 ± 245 1433 ± 2303 .518
Adrenaline_24h (µg) 92 ± 156 621 ± 1085 .354
Dobutrex_24h (µg) 71.4 ± 49.4 161.3 ± 158.9 .021
Noradrenaline_24h (µg) 266 ± 452 172 ± 203 .943
ICU, intensive care unit
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plausible candidate for such a purpose, because they are
cardiac specific and correlate directly with the number of
damaged myocytes, thus reflecting myocardial injury that
occurred during surgery [4].
This could help defuse the problem that during the earliest
hours following cardiac surgery, on-going cardiac complications
are often difficult to distinguish from transient hemodynamic
instability due to the acute postoperative condition, the
recovery from hypothermia and cardioplegia, the anesthesia or
even the transport to the ICU. As a consequence, a myocardial
cause of hemodynamic perturbations may be missed until
perioperative MI has established itself irreversibly. The present
study suggests that early TnT levels fulfill the criteria for a
specific procedural marker within a useful therapeutic window
because early TnT levels predicted outcome independently of
the patients’ preoperative risk profile (i.e. the EuroSCORE) and
independently of whether myocardial impairment was clinically
relevant or silent (i.e. independently of any need for
vasopressors). Interestingly, exposure to vasopressors during
the initial 6 hours following surgery also predicted in-hospital
outcome independently from the pre-operative EuroSCORE.
Although these data confirm recently published results [18],
they have to be validated in a larger study as well as in other
centers, knowing there is no standardized protocol and thus a
large variability among centers regarding the use of inotropes
and vasopressors after cardiac surgery [19].
Clinical decision-making is generally complicated by the fact
that TnT levels are almost always but inhomogeneously
elevated after cardiac surgery. Therefore, no clear consensus
has been reached thus far regarding timing of TnT
measurements and definition of postoperative norms.
Repetitive measurements have been suggested to determine
the peak TnT level because of its good correlation with mid-
Table 5. Assessment of early enzyme levels in 290 patients
undergoing CABG.
Laboratory without complication with complication p-Value
 (n=254) (n=36)  
Delay before 1st post-
operative laboratory analysis
(hours)
8.1 ± 1.0 8.1 ± 1 .554
CK_6 to 8h (U/l) 310.4 ± 168.9 396.9 ± 304.8 .356
CK-MB_6 to 8h (U/l) 13.2 ± 8.5 25 ± 27.2 .007
TnT_6 to 8h (ng/ml) 0.3 ± 0.2 0.7 ± 0.8 .005
Delay before 2nd post-
operative laboratory analysis
(hours)
16.1 ± 2.4 17.3 ± 2.6 .027
CK_20h (U/l) 635.7 ± 638.8 859.1 ± 1231.6 .942
CK-MB_20h (U/l) 16.1 ± 15.8 34 ± 45.3 .051
TnT_20h (ng/ml) 0.3 ± 0.2 1.0 ± 1.4 <0.001
Max_CK (U/l) 634.9 ± 631.7 840 ± 1145.8 .757
Max_CK-MB (U/l) 17.3 ± 15.6 37.6 ± 44.7 .004
Max_TnT (ng/ml) 0.3 ± 0.2 1.1 ± 1.4 .002
CK, creatine kinase; TnT, troponin T
term or even long-term outcome, which is likely based on its
reflection of irreversible myocardial injury [3,6,9–12]. By
comparison, the predictive value of early postoperative TnT
levels is clearly inferior as shown by the present study as well
as by others [5,10,13,14]. Nonetheless, according to the
Figure 2.  ROC curve analysis.  A: ROC curves for TnT
assessed at 6 to 8 hours post-surgery (AUC: 0.663; blue line)
versus 20 hours (AUC: 0.717; green line).
B: ROC curves for TnT assessed at 6 to 8 hours post-surgery
when considered alone (AUC 0.663; blue line), together with
the need of vasopressors during the first 6 hours post-surgery
(AUC: 0.726; black line), and the preoperative EuroSCORE
(AUC: 0.786 red line).
doi: 10.1371/journal.pone.0074241.g002
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present data, early TnT levels correlate well enough with
clinically important in-hospital complications to exceed the role
of a descriptive prognostic factor into a useful diagnostic tool
that could guide clinical management.
Clearly, even a robust correlation does not necessarily imply
an absolute cut-off value, below which all cases take an
uncomplicated course and vice versa. Instead, the predictive
power increases with the pretest probability as seen in the
present study when sensitivity of TnT increased notably in the
presence of another independent predictor of complications,
i.e. the need for vasopressors [18]. Thus, thresholds relate to a
number of factors including the type of procedure, the patient
population and the exact measurement timing [3,5,6,8,9,13].
The present study explored a relatively small but homogeneous
population undergoing isolated CABG procedures under MECC
[15], and evaluated a range of TnT measurements at 6 to 8
hours post-surgery. Thus, although present clinical outcomes fit
well with other recently published results of CABG,
generalization may be limited, and a causal relationship should
not be inferred from this observational data. Not only the
selected subgroup of cardiac surgery patients but also the
limited study size and the low number of observed events may
have impaired accuracy of ROC curve analyses. Therefore
above all, the study represents a robust validation of a
biologically plausible concept [3,5,6,8,9,13] and a basis for
power calculations for larger scale studies that will be
necessary to determine relative thresholds within specific
Table 6. Stratified predictive characteristics of early TNT
levels.
 All Vasopressors within first 6 hours
  No Yes
TnT Spec Sens Spec Sens Spec Sens
>1.1 .992 .194 .981 .167 1.000 .250
>1.0 .984 .222 .983 .208 1.000 .250
>0.9 .980 .222 .978 .208 1.000 .250
>0.8 .972 .278 .974 .208 .958 .417
>0.7 .949 .306 .957 .250 .875 .417
>0.6 .898 .361 .900 .333 .875 .417
>0.5 .839 .389 .843 .333 .792 .500
>0.4 .736 .444 .735 .417 .750 .500
clinical contexts. Another limitation relates to the fact that, due
to the post-hoc study design, no interventions could be based
on early TnT levels. The claim that early TnT levels may trigger
clinical and cost effective measures to prevent complications
from establishing is thus speculative and must be tested within
a completely prospective study setting. Finally, new markers,
such as the growth differentiation factor (GDF-15) or the heart-
type fatty acid binding protein (hFABP), may provide even
earlier information and with higher sensitivity [20,21] Further
investigations as well as comparisons with more traditional
approaches are, however, necessary.
Conclusion
Although TnT is elevated in almost all patients immediately
after CABG surgery, its early level may identify patients with an
increased risk of developing clinically relevant in-hospital
complications. The assumed correlation with myocardial injury
was independent of both the preoperative patient risk profile
and the immediate clinical symptoms. Therefore, early TnT
level may become a promising complementary diagnostic for
appraisal of intraoperative course and postoperative risk
stratification. Its relative cut-off level and usefulness in guiding
clinical decision-making need to be established in large-scale
prospective studies.
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